treatment revealed that the treatment of IFN-g up to 24 hours suppressed the IL-4 1 TNFa-induced CCL11 expression, whereas the CCL11 expression was enhanced 3 days after the treatment. Conclusions: These results uncovered previously unsuspected contribution of IFN-g to the fibroblasts in allergic inflammatory milieu in terms of the change in production of certain chemokines. In other words, the antagonistic function of IFN-g to Th2 cells at the early phase may represent only a small part. The intracellular signaling and IFN-g-dependent secondary events are needed to be explored to explain the long-term effect or the late phase phenomenon after IFN-g administration.
Research Unit and Department of Immunology, Institute of Ophthalmology, México D.F., Mexico; 5 Molecular Immunology Lab-I, National School of Biological Sciences, IPN, Mexico, Mexico;
6 Unidad de Desarrollo e Investigacion de Biologicos, National School of Biological Sciences, IPN, Mexico, Mexico. Background: Despite success of sublingual immunotherapy (SLIT) in the treatment of allergy diseases, more research is needed related to ocular allergy. Thus, the aim of this work was to analyze the ocular microenvironment provided by tear cytokines in allergic conjunctivitis (AC) patients treated with SLIT and to correlate tear and serum cytokines with ocular findings.
Methods: 19 AC-patients were included in this study. AC diagnosis was based on a clinical history and full ophthalmologic examination according to the diagnosis standards of the American Academy of Ophthalmology. Routine immunological studies were performed to corroborate allergic status Negative coproparasitoscopic results were documented. This study was approved by Scientific and Ethics Committees if Institute of Ophthalmology "Conde de la Valenciana," Mexico City an all subjects gave their informed consent to obtain samples. Tear and serum samples were collected to determine cytokines IL2, IL-4, IL-5, IFN-g, TNF-a, IL-10 by cytometric bead arrays (CBA), following manufacturer's instructions. Results: After 6 months of treatment with SLIT we observed significant higher IFN-g concentration, without significant changes in IL2, IL4, IL5, TNFa or IL10. We observed significant clinical improvement since 3 months of treatment and it was maintained until the end of 6 months. Clinical improvement correlated with IFN-g concentration.
Conclusions: Clinical outcome in AC-patients treated with SLIT could be tear IFN-g dependent.
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ICYT DF 08124 Background: Hypoxia-inducible factor 1 is a transcription complex that plays a pivotal role in cellular adaptation to low oxygen availability, which occurs during allergic responses, host immune defence and leukaemia progression. We investigated the role of HIF-1 in cellular adaptation to stress associated with different types of pathological reactions of immune cells. We studied IgEdependent responses of human mast cells and basophils, Toll-like receptor (TLR)-mediated innate immune reactions of human myeloid cells and stem cell factor (SCF)-mediated responses of hematopoietic cells of myeloid lineage. Methods: LAD2 human mast cells 1 , primary human basophils, and THP-1 human myeloid cells were used for investigations of FceRI, TLR ligand and SCF-induced responses. Quantitative real-time PCR, Western blot analysis, ELISA, fluorometry, luminometry and fluorescence microscopy were employed to run the assays. Results: We observed that HIF-1 activation is differentially regulated in the cases of pro-allergic, TLR-dependent and SCF-induced cellular responses. While PI3K/mTOR and MAP kinase pathways were the major contributors to HIF-1 activation during allergic/SCF-dependent responses, TLR-mediated processes occurred mostly via redox-dependent mechanisms. Experiments with HIF-1a (the inducible subunit regulating HIF-1 transactivation) knockdown cells demonstrated that HIF-1 plays a crucial role in the expression of the primary angiogenic cytokine VEGF and controls intracellular energy metabolism by regulating glycolytic metabolic activity. Conclusions: The HIF-1 transcription complex supports not only the survival of immune cells (mast cells, basophils, myeloid cells) in pathological environments but also determines their abilities to generate pro-allergic, pro-inflammatory as well as pro-angiogenic cytokines over sustained periods.
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